Fuso Pharmaceutical Industries (4538.T) Earnings Analysis

Fuso Pharmaceutical Industries (4538.T) next reports earnings on 2026-08-10. Trailing P/E 9.33.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 4538.T next report earnings?

Next earnings date2026-08-10
Consensus EPS estimaten/a
Revenue estimaten/a

4538.T earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-1299.84 JPYn/an/an/a
2025-11-1043.26 JPYn/an/an/a
2025-08-0854.14 JPYn/an/an/a
2025-05-0944.18 JPYn/an/an/a
2025-02-09101.51 JPYn/an/an/a
2024-11-10105.7 JPYn/an/an/a

4538.T valuation and analyst view

Trailing P/E9.33
Trailing EPS235.59 JPY
Price / book0.54
Dividend yield4.09%
Market cap18.83B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Fuso Pharmaceutical Industries (4538.T)'s next earnings date?

Fuso Pharmaceutical Industries is next scheduled to report on 2026-08-10.

Did 4538.T beat earnings last quarter?

Consensus estimate data was not available for 4538.T's 2026-02-12 report.

What is 4538.T's current P/E ratio and EPS?

4538.T trades at a trailing P/E of 9.33 on trailing EPS of 235.5904404873477 JPY.

What do analysts rate 4538.T?

4538.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.